MOMs (multiples of the median) and DADs (disciminant aneuploidy detection): Improved specificity and cost-effectiveness of biochemial screening for aneuploidy with DADs
- 30 April 1995
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 172 (4), 1138-1149
- https://doi.org/10.1016/0002-9378(95)91472-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Maternal serum screening for fetal down syndrome in the United States: A 1992 surveyAmerican Journal of Obstetrics and Gynecology, 1993
- A prospective trial of prenatal screening for Down syndrome by means of maternal serum α-fetoprotein, human chorionic gonadotropin, and unconjugated estriolAmerican Journal of Obstetrics and Gynecology, 1993
- Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersNew England Journal of Medicine, 1992
- Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.BMJ, 1992
- Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropinAmerican Journal of Obstetrics and Gynecology, 1990
- Maternal serum screening for Down's syndrome in early pregnancy.BMJ, 1988
- Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalitiesAmerican Journal of Obstetrics and Gynecology, 1984
- PRENATAL DIAGNOSIS OF ANENCEPHALY THROUGH MATERNAL SERUM-ALPHAFETOPROTEIN MEASUREMENTThe Lancet, 1973